Advanced search×
×

Alimentary Pharmacology and Therapeutics

Print ISSN
0269-2813
Electronic ISSN
1365-2036
Impact factor
3.861
Publisher
wiley
URL
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2036
Usage rank
554
Article count
5922
Free count
3666
Free percentage
0.619048
PDFs via platforms
Ebscoatoz, CSA, Ovid from 2000, Ebsconet, Wiley from 1987, Ebsco, Gale, and Proquest

  1. Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function - author's reply.

    Alimentary Pharmacology and Therapeutics 36(7):689 (2012) PMID 22966804

  2. Letter: anti-TNFs and psoriasis - friends or foes? Authors' reply.

    Alimentary Pharmacology and Therapeutics 36(5):498 (2012) PMID 22860614

  3. Microscopic colitis and disease associations: authors' reply.

    Alimentary Pharmacology and Therapeutics 34(7):820 (2011) PMID 21896043

  4. Night-time intra-oesophageal bile and acid exposure in GERD patients failing PPI therapy: authors' reply.

    Alimentary Pharmacology and Therapeutics 33(9):1069 (2011) PMID 21453323

  5. Dyspepsia and irritable bowel syndrome: mutually exclusive conditions? authors' reply.

    Alimentary Pharmacology and Therapeutics 32(4):613 (2010) PMID 20636623

  6. Letter from the editors.

    Alimentary Pharmacology and Therapeutics 31(1):3 (2010) PMID 20002029

  7. More statistical analysis is needed for the meta-analysis of genetic association studies: authors' reply.

    Alimentary Pharmacology and Therapeutics 29(1):144 (2009) PMID 19132969

  8. Enhancement of cytoprotective ability and cell restoration in 70-kDa heat shock protein gene-transfected rat gastric mucosal cells.

    Alimentary Pharmacology and Therapeutics 24 Suppl 4:272 (2006) PMID 17209876

    We successfully cloned HSP70 highly-expressing gastric mucosal cells, which expressed a level of HSP70 equal to 350% of that of RGM-1 cells. Over-expression of HSP70 clearly enhanced cytoprotective ability against H(2)O(2) or ethanol-induced cell damage. Wound restoration was enhanced in 7018-RGM-1...
  9. Phase I study of paclitaxel plus irinotecan combination therapy for patients with refractory and advanced gastric cancer.

    Alimentary Pharmacology and Therapeutics 24 Suppl 4:266 (2006) PMID 17209875

    Background No adequate second-line chemotherapy regimen for advanced gastric cancer is available. Aims To determine the safety and optimal dose of paclitaxel/irinotecan as a second-line chemotherapy for patients with advanced and recurrent gastric cancer. Patients and methods Sixteen patients with r...
  10. Infliximab regulates lamina propria T lymphocytes in patients with Crohn's disease.

    Alimentary Pharmacology and Therapeutics 24 Suppl 4:65 (2006) PMID 17209847

    We investigated changes in the serum level of cytokines after treatment in these patients, and the effect of infliximab in inducing the apoptosis of T lymphocytes. Methods Thirteen patients with Crohn's disease were treated with infliximab at a dosage of 5-mg/kg body weight. Clinical response was ev...